Stora Enso is a leading provider of renewable solutions in packaging, biomaterials, wood and paper on global markets. Our aim is to replace non-renewable materials by innovating and developing new products and services based on wood and other renewable materials. Our focus is on fibre-based packaging, plantation-based pulp, innovations in biomaterials and sustainable building solutions.
The Group has some 27,000 employees in more than 35 countries, and is publicly traded in Helsinki and Stockholm. Our sales in 2014 were €10.2 billion, with an operational EBIT of €810 million. The Group consists of five divisions: Consumer Board, Packaging Solutions, Biomaterials, Paper and Wood Products. Our annual production capacity is 5.4 million tons of chemical pulp, 11.7 million tons of paper and board, 1.3 billion square metres of corrugated packaging and 5.6 million cubic metres of sawn wood products, including 2.9 million cubic metres of value-added products.
Stora Enso Consumer Board division provides renewable and recyclable high-quality boards for printing and packaging applications internationally. We operate five mills in Finland, Sweden and Spain. We serve brand owners globally and are expanding in growth markets such as China, India and Pakistan to meet rising demand.
Top-quality materials and innovative solutions optimise the performance of a package in its particular user environment and marketing situation. Our wide board and barrier coating selection is ideal for imaginative packaging concepts and optimising packaging. Stora Enso Consumer Board products are used by brand owners for liquid packaging, food service and packaging, pharmaceuticals, cigarette, chocolate, cosmetics and luxury packaging. The scale and scope of Stora Enso operations make it possible to offer a versatile selection of products and solutions for different end uses and to serve our customers all over the globe.
The demands on pharmaceutical packaging are many and varied. In addition to the general requirements that apply to any consumer product, pharmaceutical packaging must also fulfil legal and safety requirements. It has to cater to specific needs, such as Braille embossing or child-safety features, and work well for inkjet and laser coding in order to increase flexibility and ensure compliance with legislative standards. Stora Enso Consumer Board has decades of experience working closely with the pharmaceutical industry. We offer renewable packaging materials, worldwide supplier reliability and industry-leading innovations.
Safety and responsibility are paramount in the pharmaceutical industry, so it's good to know that the packaging material is renewable and comes from responsibly managed sources. Excellent print performance not only improves the product's visual distinction but is also a safety issue. Stora Enso's Tambrite and Performa Bright boards perform well in converting and filling in high-speed pharmaceutical packaging lines and are widely used by pharmaceutical companies for packaging prescription and over-the-counter medicines.
Tambrite is the most valuable cartonboard brand among European brand owners (source: Cartonboard Brand Equity Tracking Survey 2014, Opticom International Research). Tambrite is ideal for prescription medicines due to its technical properties and high performance in laser coding, inkjet coding and braille embossing. For over-the-counter products Stora Enso recommends Performa Bright. In the category of generic pharmaceuticals, Tamfold can offer further savings.
Stora Enso Oyj
Kanavaranta 1 FI-00101 Helsinki, Finland
P.O. Box 309
Tel: +358 20 46 131
Fax: +358 20 46 21302